This inventor holds 1 USPTO granted patent. Top assignee: Bracco Suisse Sa. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Mathieu Hauwel
Introduction
Mathieu Hauwel is a notable inventor based in Plan-les-Ouates, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of targeting constructs that enhance therapeutic efficacy. His work is characterized by a focus on innovative solutions that address complex medical challenges.
Latest Patents
Hauwel holds a patent for a targeting construct comprising an anti-polymer antibody and contrast/therapeutic agents binding to the same. This patent details a pharmaceutical kit that includes a targeting construct, which consists of a targeting ligand and an anti-polymer antibody, along with a polymer-containing liposome or gas-filled microvesicle capable of binding or associating with the construct. The patent also discloses methods for preparing and administering this assembly, highlighting its potential applications in targeted therapy.
Career Highlights
Throughout his career, Mathieu Hauwel has been associated with Bracco Suisse SA, where he has contributed to various innovative projects. His expertise in the pharmaceutical field has allowed him to develop groundbreaking solutions that improve patient outcomes. His dedication to research and development has positioned him as a key figure in his industry.
Collaborations
Hauwel has worked alongside esteemed colleagues such as Eric Allemann and Thierry Bettinger. These collaborations have fostered an environment of innovation and have led to advancements in their respective fields.
Conclusion
Mathieu Hauwel's contributions to the pharmaceutical industry through his innovative patents and collaborative efforts exemplify the impact of dedicated inventors in advancing medical science. His work continues to inspire future innovations in targeted therapies.